Premier Alternatives

Nutromics

Brunswick, Australia · Founded 2017 · Privately Held (backing)

Developer of medical-grade diagnostics equipment designed to diagnose through their DNA-based sensor platform. Nutromics is based in Brunswick, Australia and was founded in 2017. Its last reported valuation was $153 million in May 2024. It has raised $62.5 million.

Last reported valuation
$153.3M
Oct 2026
Priced at
—
Total raised
$62.5M
Last round
—

Nutromics key facts

as of Oct 2026
  • Developer of medical-grade diagnostics equipment designed to diagnose through their DNA-based sensor platform.
  • Nutromics is valued at approximately $153.3M as of Oct 2026 (last reported valuation).
  • It has raised $62.5M; the latest was Later Stage VC ($4.9M) in Sep 2025.
  • Notable investors include MedTech Innovator, CONNECT (San Diego), Artesian, VU Venture Partners, LaunchVic — 16 tracked in total.
  • 1 investment vehicle was formed to buy Nutromics shares in the last 12 months, reporting $290K sold to 12 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$153.3M

Nutromics's last reported valuation, May 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Nutromics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Nutromics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nutromics funding rounds

No rounds on record

No funding rounds for Nutromics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Vehicles formed to buy Nutromics shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Nutromics shares, reporting $290K sold to 12 investors. Most recent filing Mar 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Companies with the most vehicle activity →

Nutromics valuation

Nutromics's last reported valuation was $153 million in May 2024. No priced round, secondary trade or fund mark has surfaced since.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy Nutromics shares, reporting $290,000 sold to 12 investors, per SEC Form D filings (most recent Mar 2026).

Nutromics investors

16 investors are on record for Nutromics, including MedTech Innovator, CONNECT (San Diego), Artesian and VU Venture Partners.

About Nutromics

Developer of medical-grade diagnostics equipment designed to diagnose through their DNA-based sensor platform. The company's technology offers a wearable sensor and software that continuously monitors biomarkers for diet, sleep, stress, and exercise and delivers real-time data and new insights for an effective lifestyle change, enabling patients to take preventative measures to reduce the risk of diabetes.

Sector
Healthcare
HQ
Brunswick, Australia
Founded
2017
Employees
63
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.